10-week, open, national, multicenter clinical trial to evaluate the safety of insulin glargine in type 2 diabetes mellitus patients, on intensified conventional therapy (ICT)

Trial Profile

10-week, open, national, multicenter clinical trial to evaluate the safety of insulin glargine in type 2 diabetes mellitus patients, on intensified conventional therapy (ICT)

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2006

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms SAFIR
  • Sponsors Sanofi
  • Most Recent Events

    • 13 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top